Skip to main content
. 2016 Jul;8(7):1587–1600. doi: 10.21037/jtd.2016.06.01

Figure 2.

Figure 2

Association between Oct-4 expression and the pathological characteristics including (A) differentiation degree, (B) TNM stage, (C) lymphatic metastasis and (D) histological subtypes of NSCLC. CI, confidence interval; NSCLC, non-small cell lung cancer; Oct-4, octamer-binding transcription factor 4; OR, odds ratio.